v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 8,920 $ 7,075
Trade accounts receivable, net 10,171 7,349
Inventories, net 16,233 17,636
Prepaid expenses and other current assets 4,479 4,881
Total current assets 39,803 36,941
Property, plant and equipment, net 4,752 4,911
Operating lease right-of-use (ROU) assets 1,007 1,128
Deferred tax assets, net 8,332 6,788
Capitalized product development cost 1,761 1,321
Other assets 411 410
Total assets 56,066 51,499
Current liabilities:    
Accounts payable 7,111 6,327
Accrued compensation and related taxes 1,755 2,289
Accrued warranty expense 992 1,008
Accrued other expenses and other current liabilities 2,712 1,894
Short-term operating lease liabilities 543 571
Deferred revenue 2,130 1,885
Total current liabilities 15,243 13,974
Long-term operating lease liabilities 602 714
Long-term uncertain tax position liability 1,419 0
Deferred revenue 6,433 6,980
Total liabilities 23,697 21,668
Commitments and contingencies
Stockholders’ equity:    
Preferred stock; $1.00 par value; 1,000,000 authorized shares; none issued or outstanding 0 0
Common stock; $0.60 par value; 10,000,000 authorized shares; 3,926,426 and 3,913,959 issued, and 3,584,346 and 3,571,879 outstanding shares as of March 31, 2025 and December 31, 2024, respectively 2,356 2,348
Additional paid-in capital 49,784 49,386
Accumulated deficit (13,718) (15,850)
Treasury stock, at cost, 342,080 shares as of March 31, 2025, and December 31, 2024 (6,053) (6,053)
Total stockholders’ equity 32,369 29,831
Total liabilities and stockholders’ equity $ 56,066 $ 51,499